Skip to main content
AAPL+0.69%MSFT+0.96%GOOGL+1.78%NVDA+3.63%AMZN+1.69%SPCX+1.42%TSM+2.92%AVGO+2.47%META+1.21%TSLA+1.46%LLY+0.01%WMT+0.08%JPM-0.04%BRK-B+0.02%V+0.01%SKHY0.00%AMD+3.30%MU+2.48%XOM0.00%JNJ+0.15%MA+0.07%ABBV+0.08%ASMLa-9.33%COST+0.19%1398.HK+0.25%KO+0.03%CVX+0.03%0700.HK-1.26%PG+0.09%CSCO+0.07%0939.HK0.00%1816.HK+3.45%HD+0.06%3988.HK-1.13%BAC+0.05%GE0.00%0857.HK-0.49%ORCL-0.01%UNH+0.02%1288.HK-0.45%PM+0.02%0005.HK-3.08%NVS-0.01%HSBA.L-3.62%INTC+3.30%AZN-0.01%MS+0.02%RTX+0.14%ORp-0.36%TMO+0.14%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%CHFJPY0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%EURPLN0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+2.62%ETHUSD+77.41%USDTUSD+0.09%XRPUSD+64.83%SOLUSD+72.04%TRXUSDT+1.22%ZECUSDT+4.60%XMRUSDT+7.10%DOGEUSD+72.43%LINKUSD+1.09%XLMUSD+1.84%BCHUSDT+2.47%LTCUSD+64.72%UNIUSD+5.11%TONUSD+74.91%SUIUSD-0.60%HBARUSDT+0.43%TAOUSDT+2.40%AAVEUSD-0.66%ONDOUSDT-0.59%DOTUSDT-1.60%ICPUSDT-5.65%WLDUSDT-0.52%ARBUSDT-0.81%ATOMUSDT-3.84%INJUSDT-4.42%STXUSDT+2.91%PYTHUSDT+0.40%TIAUSDT-1.31%FETUSDT-3.16%SEIUSDT-1.94%JUPUSDT-4.27%GRTUSDT+0.60%OPUSDT+0.63%IOTAUSDT-1.74%POLUSDT-0.11%WIFUSDT-2.78%AXSUSDT+0.59%EOSUSDT+0.77%IMXUSDT-3.33%FARTCOINUSDT-0.08%GALAUSDT-2.18%DYDXUSDT-3.45%ORDIUSDT-0.23%NOTUSDT-1.52%RONINUSDT+0.62%AAPL+0.69%MSFT+0.96%GOOGL+1.78%NVDA+3.63%AMZN+1.69%SPCX+1.42%TSM+2.92%AVGO+2.47%META+1.21%TSLA+1.46%LLY+0.01%WMT+0.08%JPM-0.04%BRK-B+0.02%V+0.01%SKHY0.00%AMD+3.30%MU+2.48%XOM0.00%JNJ+0.15%MA+0.07%ABBV+0.08%ASMLa-9.33%COST+0.19%1398.HK+0.25%KO+0.03%CVX+0.03%0700.HK-1.26%PG+0.09%CSCO+0.07%0939.HK0.00%1816.HK+3.45%HD+0.06%3988.HK-1.13%BAC+0.05%GE0.00%0857.HK-0.49%ORCL-0.01%UNH+0.02%1288.HK-0.45%PM+0.02%0005.HK-3.08%NVS-0.01%HSBA.L-3.62%INTC+3.30%AZN-0.01%MS+0.02%RTX+0.14%ORp-0.36%TMO+0.14%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%CHFJPY0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%EURPLN0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+2.62%ETHUSD+77.41%USDTUSD+0.09%XRPUSD+64.83%SOLUSD+72.04%TRXUSDT+1.22%ZECUSDT+4.60%XMRUSDT+7.10%DOGEUSD+72.43%LINKUSD+1.09%XLMUSD+1.84%BCHUSDT+2.47%LTCUSD+64.72%UNIUSD+5.11%TONUSD+74.91%SUIUSD-0.60%HBARUSDT+0.43%TAOUSDT+2.40%AAVEUSD-0.66%ONDOUSDT-0.59%DOTUSDT-1.60%ICPUSDT-5.65%WLDUSDT-0.52%ARBUSDT-0.81%ATOMUSDT-3.84%INJUSDT-4.42%STXUSDT+2.91%PYTHUSDT+0.40%TIAUSDT-1.31%FETUSDT-3.16%SEIUSDT-1.94%JUPUSDT-4.27%GRTUSDT+0.60%OPUSDT+0.63%IOTAUSDT-1.74%POLUSDT-0.11%WIFUSDT-2.78%AXSUSDT+0.59%EOSUSDT+0.77%IMXUSDT-3.33%FARTCOINUSDT-0.08%GALAUSDT-2.18%DYDXUSDT-3.45%ORDIUSDT-0.23%NOTUSDT-1.52%RONINUSDT+0.62%

Thermo Fisher sets $5 billion buyback plan

NEWS

November 5, 2026 at 23:02 UTC

3 min read
Life-science lab instruments in a bright facility symbolizing TMO stock buyback plan and capital return strategy

Key Points

  • 01Thermo Fisher (TMO)’s board approved a new $5 billion share repurchase authorization with no expiration date
  • 02The new program replaces a prior authorization that had $1 billion of capacity remaining
  • 03Buybacks may be executed via open market purchases or negotiated transactions
  • 04The decision comes alongside strong cash flow, major acquisitions and rising net debt

Thermo Fisher approves new $5 billion share repurchase plan

Thermo Fisher Scientific (TMO) has authorized a new share repurchase program of up to $5 billion of its common stock. The Board of Directors approved the authorization on November 5, 2026, establishing fresh capacity for future buybacks rather than reporting completed repurchases. The new authorization has no expiration date, giving the company flexibility over the timing and pace of any share purchases.

The program replaces a previous share repurchase authorization that had $1 billion of remaining capacity. Under the new plan, the company may buy back shares in the open market or through negotiated transactions. No specific purchase schedule or minimum repurchase amount has been announced.

Structure and mechanics of the new buyback authorization

The $5 billion authorization covers repurchases of Thermo Fisher’s common stock. Shares may be acquired through open market purchases, which allow the company to buy stock on public exchanges, or through negotiated transactions, which can include privately arranged deals. The absence of an expiration date means the authorization remains in place until fully used or replaced.

The announcement does not outline any price conditions or quarterly targets for repurchases. Instead, it provides Thermo Fisher with a broad mandate to deploy capital into buybacks when deemed appropriate. The authorization supersedes the earlier program that still had $1 billion authorized but unused.

Recent repurchase activity and capacity reset

Thermo Fisher’s new authorization follows a year of uneven repurchase activity. In the first quarter of 2026, the company spent $3 billion to buy 4.9 million shares at an average price of $616.04. In the second quarter, it spent a further $1 billion to repurchase 2.1 million shares at an average price of $482.66.

No shares were purchased in the third quarter of 2026, and company materials dated October 21, 2026 still showed $1 billion of remaining capacity under the prior authorization. The new $5 billion limit therefore replenishes and expands Thermo Fisher’s ability to conduct future buybacks beyond the earlier remaining amount.

Cash generation, capital deployment and balance sheet context

For the nine months ended September 26, 2026, Thermo Fisher generated operating cash flow of $5.867 billion and free cash flow of $4.618 billion. Over the same period, the company spent $8.877 billion on acquisitions net of cash acquired, reflecting a significant commitment to inorganic growth. It also paid $511 million in dividends while maintaining its repurchase activity earlier in the year.

As of September 26, 2026, Thermo Fisher held $5.461 billion in cash and cash equivalents and $600 million in short-term investments. Total debt stood at $41.370 billion, compared with $39.384 billion at December 31, 2025. The company reported net debt of $35.309 billion, defined as total debt less cash, cash equivalents and short-term investments, providing context for the new $5 billion buyback capacity.

Key Takeaways

  • 01Thermo Fisher (TMO)’s board has refreshed and expanded its share repurchase capacity to $5 billion, replacing a smaller remaining authorization.
  • 02The buyback approval adds flexibility to a broader capital allocation mix that already includes sizable acquisitions and cash dividends.
  • 03Stronger year-to-date cash generation supports the new authorization, even as the company carries substantial net debt on its balance sheet.

Thermo Fisher sets $5 billion buyback plan | Trading Dashboard